|Articles|March 23, 2016

iCardiac Renames Respiratory Testing Services Line

PFT Global is the renamed clinical trials division of nSpire Health, which iCardiac acquired in July 2015.

iCardiac Technologies, respiratory and cardiac safety studies services provider, unveiled PFT Global, the new name of its respiratory testing service line. The move completes a six-month process of integrating the clinical trials division of nSpire Health, which iCardiac acquired in July 2015.

Read the full release.

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

iCardiac Renames Respiratory Testing Services Line

Related Content

Why Payment Performance Has Become an Operational Brand for Sponsors: Q&A with Patrick Mizer, Ledger Run

What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale

ACT Brief: Hidden RBQM Value, Rare Disease Patient Partnership, and Safety Perception in IBD

Beyond Patient Centricity: What Rare Disease Research Gets Right

The Unquantified Value of RBQM: Reduced Rework, Data Integrity, and Inspection Readiness

Trending on Applied Clinical Trials Online

Beyond Patient Centricity: What Rare Disease Research Gets Right

What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale

The Unquantified Value of RBQM: Reduced Rework, Data Integrity, and Inspection Readiness

ACT Brief: Time Savings as RBQM Value Driver, FDA Tightens Foreign Trial Oversight, and Trusted Research Environments Versus Flat Files

Why Payment Performance Has Become an Operational Brand for Sponsors: Q&A with Patrick Mizer, Ledger Run